Global Chinese Herbal Extract Granules Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chinese Herbal Extract Granules Market Insights, Forecast to 2034
Traditional Chinese medicine formula granules are a new type of medicine with uniform specifications, uniform doses, and uniform quality standards, which are processed by extracting, separating, concentrating, drying, granulating, packaging and other production processes with traditional Chinese medicine decoction pieces as raw materials. Its active ingredients, nature, taste, indications, and efficacy are exactly the same as those of traditional Chinese medicine decoction pieces. It maintains all the characteristics of traditional Chinese medicine decoction pieces. Decoction is troublesome, but at the same time, single-flavor granules can be taken flexibly, which is hygienic and effective.
Market Analysis and InsightsGlobal Chinese Herbal Extract Granules Market
Global Chinese Herbal Extract Granules market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Chinese Herbal Extract Granules industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
In the past five years, benefiting from factors such as the improvement of people's health care knowledge, increased purchasing power, and policy support, the market size of the Chinese medicine formula granule industry has continued to grow.
Report Covers
This report presents an overview of global Chinese Herbal Extract Granules market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Chinese Herbal Extract Granules market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report

China Traditional Chinese Medicine Holdings
Tianjin Chase Sun Pharmaceutical
China Resources
Purapharm
China Shineway Pharmaceutical
Sichuan Neo-Green Pharmaceutical Technology Development
Jiangxi Baishen Pharmaceutical
Shanghai Pharmaceuticals Holding
Tasly Group
Jilin Aodong Pharmaceutical Group
Lanzhou Foci Pharmaceutical
Segment by Type
Prescription Premix
Single Pack
Medical Institutions
Retail Pharmacy
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Chinese Herbal Extract Granules introduction, etc. Chinese Herbal Extract Granules Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Chinese Herbal Extract Granules
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Chinese Herbal Extract Granules Market
Global Chinese Herbal Extract Granules market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Chinese Herbal Extract Granules industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
In the past five years, benefiting from factors such as the improvement of people's health care knowledge, increased purchasing power, and policy support, the market size of the Chinese medicine formula granule industry has continued to grow.
Report Covers
This report presents an overview of global Chinese Herbal Extract Granules market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Chinese Herbal Extract Granules market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report

By Company
China Traditional Chinese Medicine Holdings
Tianjin Chase Sun Pharmaceutical
China Resources
Purapharm
China Shineway Pharmaceutical
Sichuan Neo-Green Pharmaceutical Technology Development
Jiangxi Baishen Pharmaceutical
Shanghai Pharmaceuticals Holding
Tasly Group
Jilin Aodong Pharmaceutical Group
Lanzhou Foci Pharmaceutical
Segment by Type
Prescription Premix
Single Pack
Segment by Application
Medical Institutions
Retail Pharmacy
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Chinese Herbal Extract Granules introduction, etc. Chinese Herbal Extract Granules Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Chinese Herbal Extract Granules
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
